• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 1
      Digestive Disease Week - 2 hour(s) ago

      Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        📣 Attending #APAAM25? ➡️ Supplement your schedule with Effective Components of Collaborative Care for Depression in Primary Care: An Individual Participant Data Meta-Analysis, from JAMA Psychiatry. Free to read online during the meeting https://t.co/VNeCHQCxEe https://t.co/zts2hY2mUV

    • Mashup Score: 3
      Digestive Disease Week - 24 hour(s) ago

      Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        📌 Sports Gambling and Drinking Behaviors Over Time, from JAMA Psychiatry. ➡️ Free to read online during #APAAM25 https://t.co/0TmlW9OcLL https://t.co/yPDQW8QNgm

    • Mashup Score: 2
      Digestive Disease Week - 1 day(s) ago

      Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        📣 Attending #APAAM25? ➡️ Supplement your schedule with Once-Weekly Semaglutide in Adults With Alcohol Use Disorder, from @JAMAPsych. Free to read online during the meeting! https://t.co/o80oaBHs4g https://t.co/o9Lc7EbZC7

    • Mashup Score: 17
      Glucagon-Like Peptide 1 Receptor Agonists and Mental Health - 1 day(s) ago

      This systematic review and meta-analysis examines data for patients with diabetes and/or obesity from trials of GLP1-RA treatment to evaluate psychiatric, cognitive, and quality-of-life outcomes compared with placebo.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        Most viewed this week from @JAMAPsych: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. https://t.co/CqoUpHTpBD https://t.co/Yp9MhMW5C9

    • Mashup Score: 22
      Digestive Disease Week - 3 day(s) ago

      Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        📌 Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial, from JAMA Psychiatry. ➡️ Free to read online during #APAAM25 https://t.co/HjTnNRiJVE https://t.co/xg7iTyz6VT

    • Mashup Score: 3
      Digestive Disease Week - 3 day(s) ago

      Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        📣 Attending #APAAM25? ➡️ Supplement your schedule with Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years, from JAMA Psychiatry Free to read online during the meeting https://t.co/wWpq9Ofa8F https://t.co/bz6DGGFFem

    • Mashup Score: 16
      Digestive Disease Week - 3 day(s) ago

      Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        📌 Convergence of Cannabis and Psychosis on the Dopamine System, from JAMA Psychiatry. ➡️ Free to read online during #APAAM25! https://t.co/GBFB5sun9k https://t.co/OWq4eTgkn3

    • Mashup Score: 4
      Digestive Disease Week - 3 day(s) ago

      Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        📣 Attending #APAAM25? Check out our page created for attendees ➡️ Find recent articles and podcasts, find out when you can meet our editors, and get information for authors on @JAMA_current, JAMA Psychiatry, and @JAMANetworkOpen. https://t.co/ejWjGsPlr1 https://t.co/YH2LDzZHG0

    • Mashup Score: 45
      Purposeful Drug Repurposing - 3 day(s) ago

      This Viewpoint discusses a proposal to identify candidates for drug repurposing and allocate US Food and Drug Administration funds to cover the cost of evaluating and approving such drugs for their novel indications.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        Viewpoint: Ketamine's antidepressant potential is hindered by commercial barriers, highlighting the need for a federal program to prioritize drug repurposing based on patient needs. https://t.co/PS5HHTyEsG

    • Mashup Score: 123
      Glucagon-Like Peptide 1 Receptor Agonists and Mental Health - 3 day(s) ago

      This systematic review and meta-analysis examines data for patients with diabetes and/or obesity from trials of GLP1-RA treatment to evaluate psychiatric, cognitive, and quality-of-life outcomes compared with placebo.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        Most viewed this week from @JAMAPsych: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. https://t.co/kAdelPJqp4 https://t.co/zUFDq3U67O

    Load More

    JAMA Psychiatry

    @JAMAPsych

    International peer-reviewed journal for clinicians, scholars, and research scientists in #psychiatry, #mentalhealth, #behavioralscience, and allied fields.

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings